354 related articles for article (PubMed ID: 25224635)
1. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.
Tehrani FR; Rashidi H; Khomami MB; Tohidi M; Azizi F
Reprod Biol Endocrinol; 2014 Sep; 12():89. PubMed ID: 25224635
[TBL] [Abstract][Full Text] [Related]
2. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
[TBL] [Abstract][Full Text] [Related]
3. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.
Huang R; Zheng J; Li S; Tao T; Ma J; Liu W
Acta Obstet Gynecol Scand; 2015 May; 94(5):494-500. PubMed ID: 25711494
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of polycystic ovary syndrome in women in China: a large community-based study.
Li R; Zhang Q; Yang D; Li S; Lu S; Wu X; Wei Z; Song X; Wang X; Fu S; Lin J; Zhu Y; Jiang Y; Feng HL; Qiao J
Hum Reprod; 2013 Sep; 28(9):2562-9. PubMed ID: 23814096
[TBL] [Abstract][Full Text] [Related]
8. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
10. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
11. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
[TBL] [Abstract][Full Text] [Related]
12. Association of insulin resistance with polycystic ovary syndrome phenotypes and patients' characteristics: a cross-sectional study in Iran.
Rahmatnezhad L; Moghaddam-Banaem L; Behroozi-Lak T; Shiva A; Rasouli J
Reprod Biol Endocrinol; 2023 Nov; 21(1):113. PubMed ID: 38001527
[TBL] [Abstract][Full Text] [Related]
13. Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics.
Ates S; Sevket O; Sudolmus S; Dane B; Ozkal F; Uysal O; Dansuk R
Gynecol Endocrinol; 2013 Oct; 29(10):931-5. PubMed ID: 23998514
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
Bil E; Dilbaz B; Cirik DA; Ozelci R; Ozkaya E; Dilbaz S
J Obstet Gynaecol Res; 2016 Jul; 42(7):837-43. PubMed ID: 27071345
[TBL] [Abstract][Full Text] [Related]
15. Psoriasis and polycystic ovary syndrome: a new link in different phenotypes.
Moro F; Tropea A; Scarinci E; Federico A; De Simone C; Caldarola G; Leoncini E; Boccia S; Lanzone A; Apa R
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():101-5. PubMed ID: 26115053
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
Koo YA; Shin SY; Yoon BK; Choi D
Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
[TBL] [Abstract][Full Text] [Related]
17. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
18. Association between circulating zinc-α2-glycoprotein levels and the different phenotypes of polycystic ovary syndrome.
Tang C; Li X; Tang S; Wang Y; Tan X
Endocr J; 2020 Mar; 67(3):249-255. PubMed ID: 31748429
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
Zhang HY; Zhu FF; Xiong J; Shi XB; Fu SX
BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
[TBL] [Abstract][Full Text] [Related]
20. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
Zhang L; Fang X; Li L; Liu R; Zhang C; Liu H; Tan M; Yang G
J Endocrinol Invest; 2018 Dec; 41(12):1401-1407. PubMed ID: 29785700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
